Alternatives to Animal Testing

As per available reports about 20 Conferences, 21 Workshops and 11 Relevant Journals are presently dedicated exclusively to Toxicity Testing and about 480 articles are being published on Alternatives to Animal Testing.

OMICS International publishes more than 10 relevant journals and 4 National Symposia. National symposium and workshops provide participants with an advanced or updated review of recent advancements in the field of toxicity testing and prediction of toxicity. The conference brings together Scientists, researchers, Corporate Managers, Academicians, Decision Makers from the Pharma, Biotech and Health Care industries, Lab Directors and other experts involved in the field of Toxicology. More than 20 Global Events are going to conduct around the world.

Alternatives to animal testing has evolved mainly with the aim to avoid the use of animals for toxicological research and testing. With the increased threat of reduction in the number of animals several alternatives such as In Vitro Testing, In vivo Imaging, computational techniques are being developed.

OMICS International Organizes 1000+ Global Events Every Year across USA, Europe & Asia with support from 1000 more scientific societies and Publishes 700+ Open access journals which contains over 100000 eminent personalities, reputed scientists as editorial board and organizing committee members. The conference series website will provide you list and details about the conference organize worldwide.

OMICS International Conference Series focuses to enhance knowledge dissemination among its varied range of participants including eminent speakers, renowned scientists, industrialists from top notch companies, young researchers and students. OMICS International Pharma conferences foster the better understanding of latest scientific researches by providing a global exposure to its participants where they can associate with relatable professionals. The scope of these gatherings is further extended by encompassing remarking key areas like Pharmaceutical Regulatory Affairs, Mass Spectrometry, Separation Techniques, Toxicology , Therapeutic Drug Monitoring and Toxicogenomics, Pain Medicine, Clinical Pharmacy, GMP and GLP quality control, followed by Bioavailability and Bioequivalence studies, Biosimilars and Pharmacognosy.

Scope and Importance:

Alternatives to animal testing are the development and implementation of test methods that avoid the use of live animals. Because of widespread agreement that a reduction in the number of animals used and the refinement of testing to reduce suffering should be important goals for the industries involved. in vitro cell culture techniques and in silicocomputer simulation are two major alternatives to in vivo animal testing . However, some declare that they are not true alternatives because simulations use data from prior animal experiments and cell cultures often require animal derived products, such as cells or serum. Others say that they cannot replace animals completely as they are unlikely to ever provide enough information about the complex interactions of living systems.

Three Rs (3Rs) first described by Russell and Burch in 1959 are the principles for more ethical use of animals in testing. Many testing establishments worldwide following these principles.

Replacement refers to the preferred use of non-animal methods over animal methods whenever it is possible to achieve the same scientific aim.

Reduction refers to methods that enable researchers to obtain comparable levels of information from fewer animals, or to obtain more information from the same number of animals.

Refinement refers to methods that alleviate or minimize potential pain, suffering, or distress, and enhance animal welfare for the animals used.

Besides saving countless animal lives, alternatives to animal tests are efficient and reliable. Unlike crude, archaic animal tests, non-animal methods usually take less time to complete, cost only a fraction of what the animal experiments that they replace cost, and are not afflict with species differences that make extrapolation difficult or impossible.

An overview of the global toxicity testing market is obtained by analyses of market trends. The two major technology-based approaches utilised are mechanistic and nonmechanistic

In 2011, the global in vitro toxicity testing market was valued at $4 billion and more than $4.9 billion in 2012. This is estimated to reach around $9.9 billion in 2017, with a compound annual growth rate (CAGR) of 14.7% for the five-year period, 2012 to 2017.

Influential factors for this estimation are alternative measures for toxicity and toxicity testing, validation of the techniques for chemicals, pesticides, and food additives.

A significant share of 32% is taken up by the pharmaceutical arena which is valued at $424 million in 2010. This sector is estimated to reach a value of $976 million, at a compound annual growth rate (CAGR) of 18.2%. by 2015.